BEIRA advises on a USD 485 m sale of the biotech firm Dutalys to Roche

BEIRA served as lead counsel to all sellers of biotechnology company Dutalys to life science group Roche. Dutalys specializes in the discovery and development of fully human, bi-specific antibodies based on their proprietary DutaMabs (tm) technology.